CJC-1295 with DAC Peptide research-grade
CJC-1295 with DAC Peptide
$73.00 Add to cart
Mazdutide Peptide research-grade Mazdutide Peptide Price range: $75.00 through $99.00
Adipotide Peptide research-grade Adipotide Peptide Price range: $39.00 through $91.00

CJC-1295 with DAC Peptide

$73.00

Laboratory-grade CJC-1295 with DAC Peptide is a modified GHRH analog incorporating a Drug Affinity Complex moiety for extended half-life studies. Research buyers select this listing for pre-clinical work on growth hormone–releasing hormone pathways and prolonged peptide-exposure models—not for clinical, veterinary, or consumer use.

For Research Use Only. Not for human use.

In stock

COA CJC-1295 + DAC

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

CJC-1295 with DAC Peptide research-grade

Overview

Laboratory-grade CJC-1295 with DAC Peptide presents as a modified GHRH analog incorporating a Drug Affinity Complex moiety for extended half-life studies. Nationwide lists this SKU for controlled research programs focused on growth hormone–releasing hormone pathways and prolonged peptide-exposure models—not for clinical, veterinary, or consumer use.

Research buyers specify CJC-1295 with DAC Peptide when protocols require a characterized input for growth hormone–releasing hormone pathways and prolonged peptide-exposure models. Typical deployments include cell-based or cell-free assays, method development plates, and pathway-mapping models executed under institutional laboratory SOPs.

Use this entry when laboratory purchasing needs a stable research SKU for assay construction and notebook traceability. All handling of CJC-1295 with DAC Peptide must remain inside institutional research-use boundaries.

Research Context for CJC-1295 with DAC Peptide

Work involving CJC-1295 with DAC Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of CJC-1295 with DAC Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source CJC-1295 with DAC Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with CJC-1295 with DAC Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using CJC-1295 with DAC Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of CJC-1295 with DAC Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 89 PubMed records. Displaying 10 per page.

  1. Teichman SL et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I… [PMID: 16352683]

    Laboratory literature summary: Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  2. Van Hout MC et al. (2016). Netnography of research models Use of the Synthetic Growth Hormone CJC-1295: Pulses… [PMID: 26771670]

    Laboratory literature summary: Netnography of research models Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Timms M et al. (2019). A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS [PMID: 30938069]

    Laboratory literature summary: A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  4. Timms M et al. (2019). An immuno polymerase chain reaction screen for the detection of CJC-1295 and other… [PMID: 30489688]

    Laboratory literature summary: An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  5. Alba M et al. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone… [PMID: 16822960]

    Laboratory literature summary: Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  6. Ionescu M et al. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by… [PMID: 17018654]

    Laboratory literature summary: Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  7. Henninge J et al. (2010). Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown… [PMID: 21204297]

    Laboratory literature summary: Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Jetté L et al. (2005). Research subjects growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates… [PMID: 15817669]

    Laboratory literature summary: research subjects growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  9. Sackmann-Sala L et al. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in… [PMID: 19386527]

    Laboratory literature summary: Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  10. Hua WX et al. (2024). [CLAG±DAC regimen in the investigation of refractory/relapsed acute myeloid leukemia] [PMID: 39414607]

    Laboratory literature summary: [CLAG±DAC regimen in the investigation of refractory/relapsed acute myeloid leukemia]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  11. Zhong G et al. (2022). MAGEA1 and hTERT Peptide investigation Improves the Potency of The Dendritic Cell-… [PMID: 35281868]

    Laboratory literature summary: MAGEA1 and hTERT Peptide investigation Improves the Potency of The Dendritic Cell- Cytotoxic T Lymphocytes (DC-CTL) Immunotherapy in DAC…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  12. Author et al. (2003). Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716 [PMID: 14584964]

    Laboratory literature summary: Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  13. Bal NJS et al. (2024). A Novel and Reliable Pixel Response Correction Method (DAC-Shifting) for Spectral… [PMID: 39058061]

    Laboratory literature summary: A Novel and Reliable Pixel Response Correction Method (DAC-Shifting) for Spectral Photon-Counting CT Imaging. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  14. Chen C et al. (2015). DAC can restore expression of NALP1 to suppress oncology research models growth in… [PMID: 25611377]

    Laboratory literature summary: DAC can restore expression of NALP1 to suppress oncology research models growth in colon oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  15. Author et al. (2003). Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716 [PMID: 12757405]

    Laboratory literature summary: Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  16. Shang D et al. (2009). Synergy of 5-aza-2'-deoxycytidine (DAC) and paclitaxel in both androgen-dependent and… [PMID: 19168279]

    Laboratory literature summary: Synergy of 5-aza-2'-deoxycytidine (DAC) and paclitaxel in both androgen-dependent and -independent prostate oncology research models…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  17. Meher RK et al. (2024). Decoding dynamic interactions between EGFR-TKD and DAC through computational and… [PMID: 38685671]

    Laboratory literature summary: Decoding dynamic interactions between EGFR-TKD and DAC through computational and experimental approaches: A novel breakthrough in lung…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  18. Sommer I et al. (2020). Stability of N-Acetylcysteine (NAC) in Standardized Pediatric Parenteral Nutrition and… [PMID: 32575864]

    Laboratory literature summary: Stability of N-Acetylcysteine (NAC) in Standardized Pediatric Parenteral Nutrition and Evaluation of N,N-Diacetylcystine (DAC) Formation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  19. Jun J (2023). A Comprehensive Methodology for Optimizing Read-Out Timing and Reference DAC Offset in… [PMID: 37631585]

    Laboratory literature summary: A Comprehensive Methodology for Optimizing Read-Out Timing and Reference DAC Offset in High Frame Rate Image Sensing Systems. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  20. Mangano K et al. (2014). Hypomethylating agent 5-aza-2'-deoxycytidine (DAC) ameliorates multiple sclerosis in… [PMID: 24700487]

    Laboratory literature summary: Hypomethylating agent 5-aza-2'-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  21. Grishina O et al. (2015). Laboratory research record on CJC-1295 with DAC [PMID: 26008690]

    PubMed laboratory record discussing CJC-1295 with DAC in a research context. Review the full methods and limitations on PubMed; research use only.

  22. Cheng C et al. (2022). 4-bit DAC based 6.9Gb/s PAM-8 UOWC system using single-pixel mini-LED and digital… [PMID: 36236958]

    Laboratory literature summary: 4-bit DAC based 6.9Gb/s PAM-8 UOWC system using single-pixel mini-LED and digital pre-compensation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  23. Hao X et al. (2024). Pulse Compression Shape-Based ADC/DAC Chain Synchronization Measurement Algorithm with… [PMID: 38732937]

    Laboratory literature summary: Pulse Compression Shape-Based ADC/DAC Chain Synchronization Measurement Algorithm with Sub-Sampling Resolution. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  24. Xiao J et al. (2012). DAC is involved in the accumulation of the cytochrome b6/f complex in Arabidopsis [PMID: 23043079]

    Laboratory literature summary: DAC is involved in the accumulation of the cytochrome b6/f complex in Arabidopsis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  25. Yao T et al. (2024). Self-measurement and calibration of amplitude-frequency response for coherent optical… [PMID: 40514898]

    Laboratory literature summary: Self-measurement and calibration of amplitude-frequency response for coherent optical transmitters with limited DAC resolution. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  26. Alivand MS et al. (2023). Facile Fabrication of Monodispersed Carbon Sphere: A Pathway Toward Energy-Efficient… [PMID: 37058083]

    Laboratory literature summary: Facile Fabrication of Monodispersed Carbon Sphere: A Pathway Toward Energy-Efficient Direct Air Capture (DAC) Using Amino Acids. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  27. Tang J et al. (2024). O-band EML and 4-bits DAC enabled 112 GBaud PAM8 transmission over a 10 km SSMF… [PMID: 39602705]

    Laboratory literature summary: O-band EML and 4-bits DAC enabled 112 GBaud PAM8 transmission over a 10 km SSMF without optical amplifiers. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  28. Jang J et al. (2017). A low-cost DAC BIST structure using a resistor loop [PMID: 28212421]

    Laboratory literature summary: A low-cost DAC BIST structure using a resistor loop. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  29. Dember LM et al. (2005). Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV… [PMID: 16317810]

    Laboratory literature summary: Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  30. Li Q et al. (2025). On the performance and fiber nonlinearity modeling of learned digital back-propagation… [PMID: 40798505]

    Laboratory literature summary: On the performance and fiber nonlinearity modeling of learned digital back-propagation in the presence of DAC and ADC quantization noise. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  31. Yan A et al. (2024). Net-432-Gb/s/λ PS-PAM transmission based on advanced DSP and single DAC for 400 G/λ… [PMID: 38560829]

    Laboratory literature summary: Net-432-Gb/s/λ PS-PAM transmission based on advanced DSP and single DAC for 400 G/λ IM/DD links. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  32. Kaufmann T et al. (2013). DAC-board based X-band EPR spectrometer with arbitrary waveform control [PMID: 23999530]

    Laboratory literature summary: DAC-board based X-band EPR spectrometer with arbitrary waveform control. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  33. Olsson P et al. (1998). Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in… [PMID: 9464482]

    Laboratory literature summary: Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in cultured research subjects glioma cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  34. Berikaa E et al. (2022). Net 400-Gbps/λ IMDD transmission using a single-DAC DSP-free transmitter and a… [PMID: 37219225]

    Laboratory literature summary: Net 400-Gbps/λ IMDD transmission using a single-DAC DSP-free transmitter and a thin-film lithium niobate MZM. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  35. Zhong L et al. (2025). Channel-response-aware delta-sigma modulator design for low-resolution DAC-based… [PMID: 41185269]

    Laboratory literature summary: Channel-response-aware delta-sigma modulator design for low-resolution DAC-based pre-equalization systems. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  36. Chen M et al. (2022). Bandwidth enhancement with DAC-enabled pre-equalization and real-valued precoding for… [PMID: 36107100]

    Laboratory literature summary: Bandwidth enhancement with DAC-enabled pre-equalization and real-valued precoding for a FBMC-VLC. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  37. de Rooij MAJ et al. (2025). DNA-demethylation by DAC induces MAGE expression and MAGE-specific T cell reactivity… [PMID: 40791813]

    Laboratory literature summary: DNA-demethylation by DAC induces MAGE expression and MAGE-specific T cell reactivity against tumors but also healthy cell subsets. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  38. Stegmann AP et al. (1995). De novo induced mutations in the deoxycytidine kinase (dck) gene in rat leukemic… [PMID: 7541096]

    Laboratory literature summary: De novo induced mutations in the deoxycytidine kinase (dck) gene in rat leukemic clonal cell lines confer resistance to cytarabine…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  39. van Oort E et al. (2004). Characterization of natural Dac g 1 variants: an alternative to recombinant group 1… [PMID: 15536420]

    Laboratory literature summary: Characterization of natural Dac g 1 variants: an alternative to recombinant group 1 allergens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  40. Yanamoto K et al. (2009). Evaluation of N-benzyl-N-[11C]methyl-2-… [PMID: 19593823]

    Laboratory literature summary: Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  41. Guérin-Marchand C et al. (1996). Cloning, sequencing and immunological characterization of Dac g 3, a major allergen… [PMID: 8811075]

    Laboratory literature summary: Cloning, sequencing and immunological characterization of Dac g 3, a major allergen from Dactylis glomerata pollen. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  42. Stegmann AP et al. (1993). Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance:… [PMID: 7686601]

    Laboratory literature summary: Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  43. Luo H et al. (2022). DAC/ADC-free 4 × 12.9 Gbit/s 65,536-level quantum noise stream cipher secure optical… [PMID: 36181197]

    Laboratory literature summary: DAC/ADC-free 4 × 12.9 Gbit/s 65,536-level quantum noise stream cipher secure optical WDM transmission based on delta-sigma modulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  44. Jiang J et al. (2023). Generation of high-speed PAM-4 signal with 3-bit DAC enabled by CRD-NS in optical… [PMID: 37381221]

    Laboratory literature summary: Generation of high-speed PAM-4 signal with 3-bit DAC enabled by CRD-NS in optical interconnect. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  45. Maatuk N et al. (2015). PHI-DAC: protein homology database through dihedral angle conservation [PMID: 25252780]

    Laboratory literature summary: PHI-DAC: protein homology database through dihedral angle conservation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  46. Weber HA et al. (1990). Splenopentin (DAc-SP-5) accelerates the restoration of myelopoietic and immune systems… [PMID: 2292457]

    Laboratory literature summary: Splenopentin (DAc-SP-5) accelerates the restoration of myelopoietic and immune systems after sublethal radiation in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  47. Zeng Z et al. (2022). High-extinction-ratio low-voltage dual-racetrack modulator for low-power DAC-less… [PMID: 35167541]

    Laboratory literature summary: High-extinction-ratio low-voltage dual-racetrack modulator for low-power DAC-less PAM-4 modulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  48. Xie L et al. (2012). [(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive… [PMID: 22038158]

    Laboratory literature summary: [(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive research protocol observed endpoints in rat…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  49. Yin M et al. (2022). Multi-band DFT-S 100 Gb/s 32 QAM-DMT transmission in intra-DCI using 10 G-class EML… [PMID: 36242329]

    Laboratory literature summary: Multi-band DFT-S 100 Gb/s 32 QAM-DMT transmission in intra-DCI using 10 G-class EML and low-resolution DAC. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  50. Dubé-Demers R et al. (2016). Low-power DAC-less PAM-4 transmitter using a cascaded microring modulator [PMID: 27842134]

    Laboratory literature summary: Low-power DAC-less PAM-4 transmitter using a cascaded microring modulator. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  51. Wang W et al. (2022). Demonstration of 100-Gbit/s 32-QAM signal transmission in a radio-over-fiber system… [PMID: 36107071]

    Laboratory literature summary: Demonstration of 100-Gbit/s 32-QAM signal transmission in a radio-over-fiber system with 2-bit DAC. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  52. Knop S (2011). From the observation DAC: romidepsin revisited [PMID: 22161846]

    Laboratory literature summary: From the observation DAC: romidepsin revisited. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  53. Li Z et al. (2020). 5-aza-2'-deoxycytidine (DAC) investigation induces the MAGE-A10 expression and… [PMID: 35117468]

    Laboratory literature summary: 5-aza-2'-deoxycytidine (DAC) investigation induces the MAGE-A10 expression and improves the cytotoxicity of MAGE-A10-specific CTLs in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  54. Pietrucha K et al. (2016). Pore structure and dielectric behaviour of the 3D collagen-DAC scaffolds designed for… [PMID: 27519295]

    Laboratory literature summary: Pore structure and dielectric behaviour of the 3D collagen-DAC scaffolds designed for nerve tissue repair. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  55. Zhang J et al. (2022). Nonlinearity-aware PS-PAM-16 transmission for C-band net-300-Gbit/s/λ short-reach… [PMID: 35709043]

    Laboratory literature summary: Nonlinearity-aware PS-PAM-16 transmission for C-band net-300-Gbit/s/λ short-reach optical interconnects with a single DAC. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  56. Caubit X et al. (1999). Mouse Dac, a novel nuclear factor with homology to Drosophila dachshund shows a… [PMID: 9915577]

    Laboratory literature summary: Mouse Dac, a novel nuclear factor with homology to Drosophila dachshund shows a dynamic expression in the neural crest, the eye, the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  57. Roberts AM et al. (1992). Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that… [PMID: 1526648]

    Laboratory literature summary: Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that research subjects IgE cross-reactivity between Dac g II…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  58. Machon O et al. (2000). Yeast two-hybrid system identifies the ubiquitin-conjugating enzyme mUbc9 as a… [PMID: 11025202]

    Laboratory literature summary: Yeast two-hybrid system identifies the ubiquitin-conjugating enzyme mUbc9 as a potential partner of mouse Dac. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  59. Deniel L et al. (2019). DAC-less PAM-4 generation in the O-band using a silicon Mach-Zehnder modulator [PMID: 31045123]

    Laboratory literature summary: DAC-less PAM-4 generation in the O-band using a silicon Mach-Zehnder modulator. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  60. Stegmann AP et al. (1995). Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and… [PMID: 7532033]

    Laboratory literature summary: Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and DAC-resistant rat leukemic cell line of clonal origin fully…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  61. Yang P et al. (2025). DAC-less PAM-4 signal generation using a thin-film lithium niobate dual-drive MZI… [PMID: 40445638]

    Laboratory literature summary: DAC-less PAM-4 signal generation using a thin-film lithium niobate dual-drive MZI modulator. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  62. Lübbert M et al. (2009). Non-intensive investigation with low-exposure level 5-aza-2'-deoxycytidine (DAC) prior… [PMID: 19363531]

    Laboratory literature summary: Non-intensive investigation with low-exposure level 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  63. Nagano N et al. (1995). [Pharmacological properties of chitosan-coated dialdehyde cellulose (chitosan DAC), a… [PMID: 7557738]

    Laboratory literature summary: [Pharmacological properties of chitosan-coated dialdehyde cellulose (chitosan DAC), a newly developed oral adsorbent (II). Effect of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  64. Xing Z et al. (2018). 100 Gb/s PAM4 transmission system for datacenter interconnects using a SiP ME-MZM… [PMID: 30184891]

    Laboratory literature summary: 100 Gb/s PAM4 transmission system for datacenter interconnects using a SiP ME-MZM based DAC-less transmitter and a VSB self-coherent…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  65. Li W et al. (2019). 32-GS/s 6-bit DAC based on SiGe technology for IM-DD OFDM systems with non-uniform… [PMID: 31052635]

    Laboratory literature summary: 32-GS/s 6-bit DAC based on SiGe technology for IM-DD OFDM systems with non-uniform quantization. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  66. Li R et al. (2018). Silicon photonic dual-drive MIM based 56 Gb/s DAC-less and DSP-free PAM-4 transmission [PMID: 29529742]

    Laboratory literature summary: Silicon photonic dual-drive MIM based 56 Gb/s DAC-less and DSP-free PAM-4 transmission. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  67. Yoshimoto H et al. (1995). [Pharmacological properties of chitosan-coated dialdehyde cellulose (chitosan DAC), a… [PMID: 7557737]

    Laboratory literature summary: [Pharmacological properties of chitosan-coated dialdehyde cellulose (chitosan DAC), a newly developed oral adsorbent (I). Effect of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  68. Deng R et al. (2018). Increasing data rate of an optical IMDD system using a cost-efficient dual-band… [PMID: 29716078]

    Laboratory literature summary: Increasing data rate of an optical IMDD system using a cost-efficient dual-band transmission scheme based on RTZ DAC and sub-Nyquist…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  69. Stegmann AP et al. (1995). In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and… [PMID: 7543292]

    Laboratory literature summary: In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC) in a rat model for acute…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  70. Eckert R et al. (1990). Splenopentin (DAc-SP5)–influence on engraftment and graft-vs-host reaction after… [PMID: 2083570]

    Laboratory literature summary: Splenopentin (DAc-SP5)–influence on engraftment and graft-vs-host reaction after non-H-2 bone marrow transplantation in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  71. Huang G et al. (2021). PDM-16QAM transmission of 135 GBaud enabled by 120 GSa/s DAC and Tomlinson-Harashima… [PMID: 34525036]

    Laboratory literature summary: PDM-16QAM transmission of 135 GBaud enabled by 120 GSa/s DAC and Tomlinson-Harashima pre-coding. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  72. Willemze R et al. (1993). Preliminary results with 5-aza-2'-deoxycytidine (DAC)-containing chemotherapy in… [PMID: 7683357]

    Laboratory literature summary: Preliminary results with 5-aza-2'-deoxycytidine (DAC)-containing chemotherapy in research subjects with relapsed or refractory acute…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  73. Roberts AM et al. (1993). Nucleotide sequence of cDNA encoding the group II allergen of cocksfoot/orchard grass… [PMID: 8116860]

    Laboratory literature summary: Nucleotide sequence of cDNA encoding the group II allergen of cocksfoot/orchard grass (Dactylis glomerata), Dac g II. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  74. Yamasaki T et al. (2010). Imaging of peripheral-type benzodiazepine receptor in oncology research models: carbon… [PMID: 19851043]

    Laboratory literature summary: Imaging of peripheral-type benzodiazepine receptor in oncology research models: carbon ion irradiation reduced the uptake of a positron…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  75. Yin M et al. (2021). Transmission of a 56 Gbit/s PAM4 signal with low-resolution DAC and pre-equalization… [PMID: 34780419]

    Laboratory literature summary: Transmission of a 56 Gbit/s PAM4 signal with low-resolution DAC and pre-equalization only over 80 km fiber in C-band IM/DD systems for…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  76. Rüter B et al. (2007). Preferential cytogenetic response to continuous intravenous low-exposure level… [PMID: 17644749]

    Laboratory literature summary: Preferential cytogenetic response to continuous intravenous low-exposure level decitabine (DAC) administration in myelodysplastic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  77. Schwartsmann G et al. (1997). Decitabine (5-Aza-2'-deoxycytidine; DAC) plus daunorubicin as a first line… [PMID: 9130689]

    Laboratory literature summary: Decitabine (5-Aza-2'-deoxycytidine; DAC) plus daunorubicin as a first line investigation in research subjects with acute myeloid…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  78. Tashiro H et al. (1999). [Effects of DAC (doxifluridine, adriamycin, cyclophosphamide) chemotherapy in advanced… [PMID: 10410146]

    Laboratory literature summary: [Effects of DAC (doxifluridine, adriamycin, cyclophosphamide) chemotherapy in advanced breast oncology research models research subjects]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  79. Leduc-Brodard V et al. (1996). Characterization of Dac g 4, a major basic allergen from Dactylis glomerata pollen [PMID: 8977507]

    Laboratory literature summary: Characterization of Dac g 4, a major basic allergen from Dactylis glomerata pollen. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  80. Piron-Fraipont C et al. (1990). Transcriptional analysis of the DD-peptidase/penicillin-binding protein-encoding dac… [PMID: 2175384]

    Laboratory literature summary: Transcriptional analysis of the DD-peptidase/penicillin-binding protein-encoding dac gene of Streptomyces R61: use of the promoter and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  81. Yui J et al. (2010). Imaging of the translocator protein (18 kDa) in rat brain after ischemia using… [PMID: 20175226]

    Laboratory literature summary: Imaging of the translocator protein (18 kDa) in rat brain after ischemia using [11C]DAC with ultra-high specific activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  82. Brenner J et al. (1983). Chemotherapy of research subjects with advanced soft tissue sarcoma with use of DVA… [PMID: 6349786]

    Laboratory literature summary: Chemotherapy of research subjects with advanced soft tissue sarcoma with use of DVA (vindesine sulfate), adriamycin and cyclophosphamide…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  83. Thompson D et al. (2006). Pulse oximeter improvement with an ADC-DAC feedback loop and a radial reflectance sensor [PMID: 17946003]

    Laboratory literature summary: Pulse oximeter improvement with an ADC-DAC feedback loop and a radial reflectance sensor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  84. Eckert R et al. (1989). Splenopentin (DAc SP-5)-accelerated reconstitution of antibody formation after… [PMID: 2689191]

    Laboratory literature summary: Splenopentin (DAc SP-5)-accelerated reconstitution of antibody formation after syngeneic bone marrow transplantation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  85. Thomson AE et al. (1983). Inhibition by colchicine of research subjects lymphocytotoxic function: dependence on… [PMID: 6855266]

    Laboratory literature summary: Inhibition by colchicine of research subjects lymphocytotoxic function: dependence on cell-bound drug level, spontaneous reversibility…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  86. Cartledge JC et al. (2011). Pulse shaping for 112 Gbit/s polarization multiplexed 16-QAM signals using a 21 GSa/s DAC [PMID: 22274080]

    Laboratory literature summary: Pulse shaping for 112 Gbit/s polarization multiplexed 16-QAM signals using a 21 GSa/s DAC. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  87. Eckert R et al. (1989). Prevention of graft-vs-host reaction induced immunodeficiency by investigation with… [PMID: 2624251]

    Laboratory literature summary: Prevention of graft-vs-host reaction induced immunodeficiency by investigation with splenopentin (DAc-SP5). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  88. Chemla ES et al. (2008). A European perspective on the Dialysis Access Consortium (DAC) study regarding the… [PMID: 19085890]

    Laboratory literature summary: A European perspective on the Dialysis Access Consortium (DAC) study regarding the effects of clopidogrel on early failure of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  89. Horiuchi Y et al. (1997). Systemic 70% deacetylated chitin (DAC-70) as a investigation for MRL/1pr murine lupus;… [PMID: 9046746]

    Laboratory literature summary: Systemic 70% deacetylated chitin (DAC-70) as a investigation for MRL/1pr murine lupus; reduction of immunoglobulin deposition in the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight.125 lbs
Dimensions9 × 7 × .5 in
Size

5mg, 10mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is CJC-1295 with DAC peptide?

CJC-1295 with DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) combined with Drug Affinity Complex (DAC) technology. It is studied in research laboratories for its role in endocrine signaling and growth hormone-related pathways.

What is CJC-1295 with DAC used for in research?

CJC-1295 with DAC is used in research laboratories to investigate peptide-receptor interactions, endocrine signaling, and growth hormone pathway activity. It is not approved for human use.

Is CJC-1295 with DAC Peptide approved or intended for human use?

No. CJC-1295 with DAC is strictly intended for research purposes only and is not approved by the FDA for human use.

Is CJC-1295 with DAC Peptide FDA-approved for medical or clinical use?

No. CJC-1295 with DAC is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is CJC-1295 with DAC supplied?

CJC-1295 with DAC is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should CJC-1295 with DAC be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for CJC-1295 with DAC?

CJC-1295 with DAC is available in multiple vial sizes.

Is CJC-1295 with DAC Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is CJC-1295 with DAC shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://nationwidepeptides.com/shipping-and-payments

How can I verify CJC-1295 with DAC purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://nationwidepeptides.com/coa/

Frequently bought together

CJC-1295 with DAC Peptide research-grade
CJC-1295 with DAC Peptide
$73.00
+
Bacteriostatic Water (Bac Water) research-grade
Bacteriostatic Water (Bac Water) - 10ml
$15.00

Frequently Asked Questions

What is CJC-1295 with DAC peptide?
CJC-1295 with DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) combined with Drug Affinity Complex (DAC) technology. It is studied in research laboratories for its role in endocrine signaling and growth hormone-related pathways.
What is CJC-1295 with DAC used for in research?
CJC-1295 with DAC is used in research laboratories to investigate peptide-receptor interactions, endocrine signaling, and growth hormone pathway activity. It is not approved for human use.
Is CJC-1295 with DAC Peptide approved or intended for human use?
No. CJC-1295 with DAC is strictly intended for research purposes only and is not approved by the FDA for human use.
Is CJC-1295 with DAC Peptide FDA-approved for medical or clinical use?
No. CJC-1295 with DAC is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.
In what form is CJC-1295 with DAC supplied?
CJC-1295 with DAC is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.
How should CJC-1295 with DAC be stored?
Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.
What vial sizes are available for CJC-1295 with DAC?
CJC-1295 with DAC is available in multiple vial sizes.
Is CJC-1295 with DAC Peptide sold as a prescription product?
No prescription is required; however, it is sold strictly for research use only.
How is CJC-1295 with DAC shipped?
Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://nationwidepeptides.com/shipping-and-payments
How can I verify CJC-1295 with DAC purity and quality?
Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://nationwidepeptides.com/coa/
SKU: cjc1295-dac-5-mg Category: Tags: , , , , , , , , Brand:

Related products